TP53 and invasive breast carcinoma: Recently, using a syngeneic genetically engineered mouse model of invasive breast cancer driven by ablation of both PTEN and TRP53, Bergholz et al. [66] demonstrated that in tumors with PTEN loss, the kinase PI3Kβ promotes immune evasion by upregulation of STAT3.